إعلان
إعلان

SMLR

SMLR logo

Semler Scientific, Inc.

19.28
USD
برعاية
-1.39
-6.72%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
exchange

بعد الإغلاق

19.48

+0.20
+1.06%

تقارير أرباح SMLR

النسبة الإيجابية المفاجئة

SMLR تفوق 25 من 30 آخر التقديرات.

83%

التقرير التالي

بيانات التقرير القادم
١٦ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$6.79M
/
$0.04
التغير الضمني من Q3 25 (Revenue/ EPS)
-9.33%
/
-96.26%
التغير الضمني من Q4 24 (Revenue/ EPS)
-45.27%
/
-98.83%

Semler Scientific, Inc. earnings per share and revenue

On ١٢ نوفمبر ٢٠٢٥, SMLR reported earnings of 1.07 USD per share (EPS) for Q3 25, beating the estimate of 0.05 USD, resulting in a 1998.04% surprise. Revenue reached 7.49 مليون, compared to an expected 8.02 مليون, with a -6.63% difference. The market reacted with a -10.61% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 المحللين forecast an EPS of 0.04 USD, with revenue projected to reach 6.79 مليون USD, implying an نقصان of -96.26% EPS, and نقصان of -9.33% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
AngioDynamics, Inc.
Report Date
٠٦ يناير ٢٠٢٦ إلى ربع سنوي2 26
تقدير
-$0.10
الفعلي
$0.00
مفاجئة
+100.00%
الأسئلة الشائعة
For Q3 2025, Semler Scientific, Inc. reported EPS of $1.07, beating estimates by 1998.04%, and revenue of $7.49M, -6.63% below expectations.
The stock price moved down -10.61%, changed from $25.73 before the earnings release to $23.00 the day after.
The next earning report is scheduled for ١٦ فبراير ٢٠٢٦.
Based on 4 المحللين, Semler Scientific, Inc. is expected to report EPS of $0.04 and revenue of $6.79M for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان